ArticleBioinformation2026
Intravenous versus inhalational maintenance anaesthesia on postoperative recovery parameters after general anaesthesia: A randomized controlled study.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Total intravenous anaesthesia (TIVA) using propofol-remifentanil versus sevoflurane maintenance affects postoperative recovery, PONV and patient outcomes in laparoscopic surgery, though evidence varies. Hence, this randomised trial compared TIVA (n=60) versus sevoflurane (n=60) in 120 ASA I-III adults undergoing elective laparoscopic cholecystectomy with standardised protocols. TIVA accelerated extubation (7.4 ±2.1 vs 9.6±2.5 min; p<0.001), Aldrete ≥9 recovery (23.1±4.8 vs 29.2±6.1 min; p<0.001) and shortened PACU stay (40 [35-45] vs 50 [42-60] min; p=0.002). TIVA reduced PONV incidence (20% vs 38.3%; p=0.03) with less rescue antiemetic use, while pain scores and opioid requirements stayed comparable between groups. Propofol-remifentanil TIVA optimises early recovery, lowers PONV and boosts 24-hour QoR-15 scores versus sevoflurane, positioning it as the superior choice for enhanced postoperative outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.